[1]
“Efficacy of Bezlotoxumab in Preventing Recurrent Clostridioides Difficile Infection: A Narrative Review”, AMMS, pp. 1096–1102, Sep. 2025, Accessed: Oct. 20, 2025. [Online]. Available: https://ammspub.com/index.php/amms/article/view/329